Pregnancy: There are limited clinical data available on exposed pregnancies. ARIXTRA should not be prescribed to pregnant women unless the benefit outweighs the risk.
Lactation: Fondaparinux is excreted in rat milk but it is not known whether fondaparinux is excreted in human milk. Breast-feeding is not recommended during treatment with ARIXTRA.